This study tested a personalized vaccine made from each patient's own melanoma mutations. The goal was to see if it is safe and possible to create such a vaccine. Fifteen people with advanced melanoma received the vaccine, and researchers checked for side effects and immune respo…
Phase: PHASE1 • Sponsor: Patrick Ott, MD, PhD • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:07 UTC